ArticlePDF Available

A REVIEW ON: HIV AIDS

Authors:
  • Himalayan Institute of Pharmacy, Kala amb ,district sirmour , Himachal Pradesh

Abstract

HIV/AIDS has always been one of the most thoroughly global of diseases. The human immunodeficiency virus (HIV) is a lent virus that causes HIV infection and AIDS. AIDS is a condition in humans in which progressive failure of the immune system allows life-threatening infections and cancers to thrive. Infection with HIV occurs by the transfer of blood, semen, vaginal fluid, breast milk. Within these bodily fluids, HIV is present as both free virus particles and virus within infected immune cells. HIV infects vital cells in the human immune system such as helper CD4 T cells, macrophages. HIV infection leads to low levels of T cells through a number of mechanisms, including pyroptosis of infected T cells. The symptoms of AIDS are primarily the result of conditions that do not normally develop in individuals with healthy immune systems. Most of these conditions are opportunistic infections caused by bacteria, viruses, fungi and parasites that are normally controlled by the elements of the immune system that HIV damages. When condoms are used consistently by a couple in which one person is infected, the rate of HIV infection is less than 1% per year. There is some evidence to suggest that female condoms may provide an equivalent level of protection.
*Corresponding Author: Arpita Kapila, L.R Institute of Pharmacy, Solan, Himachal Pradesh, India. E-Mail:
arpitakapila4@gmail.com 69
Indian J. Pharm. Biol. Res. 2016; 4(3):69-73
Review Article
A REVIEW ON: HIV AIDS
Kapila A1*, Chaudhary S1, Sharma RB1, Vashist H1, Sisodia SS2, Gupta A1,2
1L.R. Institute of Pharmacy, Solan (H.P.), India
2Department of Pharmacy, B.N. University, Udaipur (Raj.), India
ARTICLE INFO:
Article history:
Received: 10 July 2016
Received in revised form:
18 August 2016
Accepted: 20 August 2016
Available online: 30September 2016
Keywords:
AIDS,
Transmission,
Symptoms.
ABSTRACT
HIV/AIDS has always been one of the most thoroughly global of diseases. The human
immunodeficiency virus (HIV) is a lent virus that causes HIV infection and AIDS. AIDS is a
condition in humans in which progressive failure of the immune system allows life-threatening
infections and cancers to thrive. Infection with HIV occurs by the transfer of blood, semen, vaginal
fluid, breast milk. Within these bodily fluids, HIV is present as both free virus particles and virus
within infected immune cells. HIV infects vital cells in the human immune system such as helper
CD4 T cells, macrophages. HIV infection leads to low levels of T cells through a number of
mechanisms, including pyroptosis of infected T cells. The symptoms of AIDS are primarily the
result of conditions that do not normally develop in individuals with healthy immune systems.
Most of these conditions are opportunistic infections caused by bacteria, viruses, fungi and
parasites that are normally controlled by the elements of the immune system that HIV damages.
When condoms are used consistently by a couple in which one person is infected, the rate of HIV
infection is less than 1% per year. There is some evidence to suggest that female condoms may
provide an equivalent level of protection.
Introduction
HIV stands for human immunodeficiency virus. AIDS stands
for acquired immuno deficiency syndrome.
HIV
H-It infects only human beings and also transmitted between
humans not from animals. It is not transmitted from bites of
mosquitoes, bats or any other species.
I-The body has immune system whose function is to protect our
body from germs, infections etc. But a person suffering from
HIV has inability to fight against diseases. However, immune
system becomes deficient.
V-Virus is a small, simplest thing which is in inactive form
outside the body and becomes active when it goes inside human
body.
AIDS
A-It is not inherited means it cannot be transmit from one
generation to another. It is transmitted to healthy person by
infected person.
I-It weakens the immune system.
D-Creates a deficiency of CD4+ cells in the immune system.
S-It is a collection of diseases.
HIV is a virus that causes AIDS. Normally, our body has
immune system that attack viruses and bacteria. Immune
system has white blood cells which protect us from infections.
White blood cells contain CD4+ cells which is also known as
helper cells or T cells. A person who is infected will be able to
develop. These infections take advantage of body’s immune
system. These infections cause several health problems and
even lead to death of a person. HIV has inability to protect
against diseases and count of CD4 cells also decreases in HIV.
There is no cure of AIDS but there are certain medicines which
are use to slow down the diseases so you stay healthier for long
time. There is no medicine to get rid of diseases [1].
HIV is a virus that causes AIDS. Normally, our body has
immune system that attack viruses and bacteria. Immune
system has white blood cells which protect us from infections.
White blood cells contain CD4+ cells which is also known as
helper cells or T cells. A person who is infected will be able to
develop. These infections take advantage of body’s immune
system. These infections cause several health problems and
even lead to death of a person. HIV has inability to protect
CODEN (USA): IJPB07 ISSN: 2320-9267
Indian Journal of Pharmaceutical and Biological Research (IJPBR)
Journal homepage: www.ijpbr.in
Kapila et al / Indian J. Pharm. Biol. Res., 2016; 4(3):69-73
Review Article 70
against diseases and count of CD4 cells also decreases in HIV.
There is no cure of AIDS but there are certain medicines which are use to slow down the diseases so you stay healthier for long
time. There is no medicine to get rid of diseases [1].
Structure of HIV Virus
Fig.1: Structure of HIV Virus
Gp120
The 120 in its name comes from its molecular weight. It is
essential for virus entry into the cells as it plays vital role in
attachment to specific cell surface receptors.
GP41
It is a subunit of the envelope protein complex of retroviruses
including human immuno deficiencies virus. It is family of
enveloped viruses that replicate in host cell through process
of reverse transcriptase. It targets a host cell.
Viral envelope
It is envelope through which virus binds.
P17
Viral core is made from protein. It is bullet shaped. Three
enzymes required for HIV replication are reverse
transcription, integrase and protease.
P24
P24 is component of HIV capsid.
Protease
It is a retroviral aspartyl protease that is essential for life
cycle of HIV, the retrovirus that caused AIDS. This enzyme
cleaves newly synthesized polyproteins at appropriate place
to create nature protein components of infectious HIV virion.
Integrase
Enzyme produce by retrovirus that enables its genetic
material to be integrated into the DNA of infected cell.
RNA
All organisms including most viruses store their genetic
material on long strands of DNA. Retrovirus is exception
because their genes are composed of RNA [2].
Causes
It is caused by sexual contact from one person to another
person. HIV is a virus. When someone becomes infected with
HIV the virus weakens and damages their body’s defence
system (the immune system) so that it cannot fight off
infections.
It is cause by:
a. Sharing drug needles or syringes.
b. Sexual contact including oral, vaginal or oral who is HIV
positive.
c. Having other sexually transmitted diseases such as
syphilis, herpes, and gonorrhea seems to increase the risk of
being infected by HIV during unprotected sexual contact with
infected partner.
d. Babies can be infected by an HIV-positive mother during
pregnancy, birth and breast feeding.
Transmission
HIV is transmitted principally in three ways: By sexual
contact, by blood through transfusion, blood products or
contaminated needles or by passage from mother to child.
Although homosexual contact remains a major source of HIV
within the United States, “hetero sexual transmission is the
most important means of HIV spread worldwide today.”
Treatment of blood products and donor screening has
essentially eliminated the risk of HIV from contaminated
blood products in developed countries, but its spread
continues among intravenous drug users who share needles.
In developing countries, contaminated blood and
contaminated needles remain important means of infection.
Thirteen to thirty-five percent of pregnant women infected
with HIV will pass the infection on to their babies;
transmission occurs before as well as during birth. Breast
milk from infected mothers has been shown to contain high
levels of the virus also.
HIV is not spread by the fecal-oral route; aerosols; insects;
or casual contact, such as sharing household items or
hugging. The risk to health care workers is primarily from
direct inoculation by needle sticks. Although saliva can
Kapila et al / Indian J. Pharm. Biol. Res., 2016; 4(3):69-73
Review Article 71
contain small quantities of the virus, the virus cannot be
spread by kissing.
HIV can be transmitted from an infected person to another
through:
Blood (including menstrual blood),
Semen,
Vaginal secretions,
Breast milk.
Activities That Allow HIV Transmission
• Unprotected sexual contact
Direct blood contact, including injection drug needles,
blood transfusions, accidents in health care settings or certain
health care products.
• Mother to baby (before or during birth) [2].
HIV is known to be transmitted only through:
Contact of infected blood, semen, or vaginal and cervical
secretions with mucous membranes.
• Injection of infected blood or blood products.
• Vertical transmission (that is, from infected mother to fetus)
and from mother to infant via breast milk.
Contact of Sexual Fluids or Blood with Mucous
Membranes:
The virus cannot pass through undamaged skin. HIV can
enter the body through the mucous membranes that line the
vagina, rectum, urethra, and possibly, on rare occasions, the
mouth. Damage to a mucous membrane may increase the risk
of transmission of HIV but is not necessary for transmission
to occur.
Injection of Infected Blood:
HIV can be transmitted by infected blood getting directly into
the bloodstream through intravenous, intramuscular, or
subcutaneous injection.
Blood-to-blood transmission occurs in the following ways:-
• Transfusion of contaminated blood and blood products and
other blood recipients.
• Sharing of unsterilized hypodermic needles and syringes.
The risk of HIV Transmission is dependent on:
The concentration of HIV in the infected fluid.
The QUANTITY of fluid introduced into the body.
The ACCESS of the infected fluid to the t4 cells.
Fluid with high concentration of HIV:
Semen,
Blood and blood components,
Menstrual flow,
Vaginal secretions,
Pre ejaculatory fluid,
Breast milk.
Fluids with LOW Concentration of HIV
Pus,
Saliva,
Tears,
Urine,
Feces,
Vomiting,
Nasal mucosa.
Symptoms
Many people who are living with HIV have no obvious signs
and symptoms at all. Recent evidence shows that between
70% to 90% of people who become infected with HIV
experience flu-like symptoms within a few weeks after
infection. The most common symptoms are a fever, a rash
and a severe sore throat all occurring at the same time. These
symptoms in an otherwise healthy person may indicate recent
HIV infection.
HIV infected patients may get yeast infections (oral or
vaginal) that do not go away or that occur often. Frequent and
severe herpes infections that cause mouth, genital, or anal
sores are also common.
Herpes zoster (shingles) is more likely to occur in infected
patients. Other pulmonary infections (pneumonia) or so-
called atypical mycobacterial infections can be serious for
your loved one. Women may get pelvic inflammatory disease
that does not respond to treatment. The virus may attack the
nervous system (nerves, spinal cord or brain) and produce a
variety of symptoms ranging from tingling in the feet and
trouble walking to memory disturbances [3].
Symptoms
large lymph nodes or "swollen glands" that may be
enlarged,
for more than three months,
frequent fevers and sweats skin rashes or flaky skin that
does not go away,
short-term memory loss,
slow growth or frequent illness in children,
cough and shortness of breath,
seizures and lack of coordination,
difficult or painful swallowing,
confusion and forgetfulness nausea, cramps diarrhea or
vomiting that do not go away,
vision loss,
Unexplained weight loss.
Kapila et al / Indian J. Pharm. Biol. Res., 2016; 4(3):69-73
Review Article 72
Life Cycle of HIV AIDS
Fig. 2: Life cycle of HIV AIDS
Entry to human cells
HIV is the only viruses which make new copies of itself
inside the human cells. This process begins when this virus
enters into cell that carries on its surface a protein that is cd4.
The HIV virus stick to the cd4 receptor and allow them to
fuse.HIV mainly infect immune cells i.e. T-helper cells that
forms the body immune system. HIV infects more cells,
therefore immune system becomes weak.
Reverse transcription
There is an enzyme reverse transcriptase which helps in
reverse Transcription. The main function of reverse
transcriptase is conversion of viral RNA into DNA. After that
DNA is transported to cell’s nucleus where insertion of DNA
is done by enzyme integrase.
Transcription and translation
Now, transcription takes place. HIV virus converts HIV virus
into messenger RNA.
Assembly, budding and maturation
Copies of HIV gather together with newly made HIV protein
and enzymes to form new viral particle which are then bud
off from the original CD4 cell. The enzyme protease break
the long chains of HIV protein into smaller pieces. These
newly virus has ability to target and infect other CD4 cells
[4].
Diagnosis
HIV is most commonly diagnosed by testing your blood or
saliva for antibodies to the virus. Unfortunately it takes time
for your body to develop these antibodies-usually up to 12
week. A newer type of test that checks for HIV antigen, a
protein produced by the virus immediately after infection,
can quickly confirm a diagnosis soon after infection [5].
Following are the tests for detection of HIV AIDS:
Home Test
A Food and Drug Administration-approved home test. To do
the test, you swab fluid from your upper and lower gums. If
the test is positive, you need to see your doctor to confirm the
diagnosis. If the test is negative, it needs to be repeated in
three months to confirm the results.
Tests To Tailor Treatment
If you receive a diagnosis of HIV/AIDS, several types of
tests can be done. These tests include:
CD4 count
CD4 cells are a type of white blood cell that's specifically
targeted and destroyed by HIV.
Viral load
This test measures the amount of virus in your blood. Studies
have shown that people with higher viral loads generally fare
more poorly than do those with a lower viral load.
Drug resistance
This blood test determines whether the strain of HIV you
have will be resistant to certain anti-HIV medications [6].
Treatment
Antiretroviral drugs are used to treat HIV. These are the
drugs active against human immunodeficiency virus (HIV)
which is a retrovirus. They are useful in prolonging and
improving a quality of life. Antiretroviral drugs are classified
as following:
Kapila et al / Indian J. Pharm. Biol. Res., 2016; 4(3):69-73
Review Article 73
Nucleoside reverse transcriptase inhibitors (NRTIs):
Zidovudine (AZT), Didanosine,Lamivudine, Tenofovir.
Nonnucleoside reverse transcriptase inhibitors:
Nevirapine, Delavirdine, Efavirenz.
Protease inhibitors:
Indinavir, Nelfinavir, Amprenavir, Lopinavir, Atazanavir.
Nucleoside analogue reverse transcriptase inhibitors
(NRTIs) were the first type of drug available to treat HIV
infection in 1987. When HIV infects a cell, it copies its own
genetic code into the cell’s DNA, and the cell is then
programmed to create new copies of HIV.
To reproduce, HIV must first convert its RNA into DNA
using the enzyme reverse transcriptase.
These inhibitors act like false building blocks and compete
with the cell’s nucleosides, thereby preventing DNA
synthesis.
Non nucleoside reverse transcriptase inhibitors (NNRTIs)
started to be approved in 1997. These also interfere with
HIV’s ability to infect cells by targeting reverse transcriptase.
In contrast to nucleoside analogue reverse transcriptase
inhibitors, non nucleosides bind directly to the enzyme [7].
HAART
It is highly active antiretroviral therapy. HIV can also be
treated by HAART. It is a combination of three drugs.
Conclusion
Historically, HIV prevention programs have focused
primarily on developing risk reduction interventions for those
at high risk for becoming infected with HIV. In 1999, a
review of 55 state and city applications to the CDC for funds
for HIV prevention programs demonstrated that only 18
(32.7%) listed HIV-infected individuals as a priority
population for HIV prevention programs. Although there are
millions of people in the United States at "behavioral risk"
for HIV infection, transmission can occur only from people
who are infected with the virus. As the number of individuals
with HIV continues to increase because of ART, so does the
urgency for lifelong prevention strategies customized for
them.
Conflict of interest: We declare that we have no conflict of
interest.
References
1. Coffin, J. M. Molecular biology of HIV. In The
Evolution of HIV, ed. K. A. Crandall, 1999; 3-40.
2. Friedland, G. and Klein R. Transmission of HIV. Nejm
1987; 317:18: 1125-1135.
3. Downs, A.M. and De I. Vincenzi. Probability of
heterosexual transmission of HIV: relationship to the
number of unprotected sexual contacts. Europeon study
Group in heterosexual transmission of HIV. J. A cquir
Immune Defic Syndr Hum Retroviral 1996; 11(4): 388-
95.
4. Amborzia, J. and Levy J. A. Epidemiology, natural
history and Pathogenesis of HIV Infection. In Sexually
Transmitted Diseases, 3d ed, ed. K.K. Holmes, P.F.
Sparling, P.A. Mardh, S.M. Lemon, W.E. Stamm, P.
Piot, and J.N. Wasserheit, 1998; 25158.
5. Palella, F.J., Delaney, K.M., Moorman, A.C., Loveless,
M.O., Fuhrer, J., Satten, G.A., Aschman, D.J. and
Holmberg, S.D. Declining Morbidity and Mortality
among Patients with Advanced Human
Immunodeficiency Virus Infection; N England Journal
of Medicine 1998; 338: 853860.
6. Pope, M. and Haase, A. Transmission; acute HIV-1
infection and the quest for strategies to prevent
infection. Natural Medicine 2003; 9(7): 847852.
7. Tripathi, K.D. Essentials of Medical Pharmacology, 6th
edition, Jaypee brothers, medical publishers ltd., New
Delhi; 798-810.
All © 2016 are reserved by Indian Journal of Pharmaceutical and Biological Research
This Journal is licensed under a Creative Commons Attribution-Non Commercial -Share Alike 3.0 Unported License. This article can be downloaded to
ANDROID OS based mobile
Cite this article as: Kapila A, Chaudhary S, Sharma RB, Vashist H, Sisodia SS, Gupta A. A REVIEW ON: HIV AIDS. Indian J.
Pharm. Biol. Res.2016; 4(3):69-73.
. Antibacterial and antifungal evaluation of some chalcogen bearing ligands, their transition and non-transition metal complexes.
Indian J. Pharm. Biol. Res.2015; 3(3):1-6.
... It is important to highlight some of the main assumptions in the model formulation 1. Infection of both diseases can be transmitted from parents to offspring during pregnancy. (see [4,12,13]) 2. There is no recovery from HIV/AIDS infection [4]. ...
... It is important to highlight some of the main assumptions in the model formulation 1. Infection of both diseases can be transmitted from parents to offspring during pregnancy. (see [4,12,13]) 2. There is no recovery from HIV/AIDS infection [4]. ...
... Modification parameter that accounts for increased level of infectiousness from . 4 Modification parameter that accounts for reduced transmission from . Modification parameter that accounts for decrease in sexual activity by individuals with ZIKV symptoms (due to ill health). ...
Article
Full-text available
The co-infection of HIV and Zika virus (ZIKV) poses a complex and understudied health challenge, requiring a comprehensive investigation into the synergistic effects, potential complications, and the impact on affected individuals. Consequently, This paper introduces a novel deterministic mathematical model that examines the transmission dynamics of HIV and Zika virus co-infection, considering both vertical and horizontal transmission. The analysis begins with two sub-models: one for HIV-only and another for ZIKV-only. Qualitative examination indicates that the HIV only sub-model achieves a globally asymptotically stable disease-free equilibrium when the associated reproduction number is below unity. In contrast, the ZIKV only sub-model exhibits a backward bifurcation phenomenon, where both stable disease-free and stable endemic equilibria co-exist when the associated reproduction number of the ZIKV only sub-model is less than unity. Thus, the backward bifurcation property makes effective control of ZIKV infection in the population difficulty when the associated reproduction number is less than unity. It is shown, using the centre manifold theory that the full HIV-ZIKV co-infection model undergoes the phenomenon of backward bifurcation. We carried out the sensitivity analysis of the HIV and ZIKV basic reproduction numbers to determine the parameters that positively influence the spread of the two diseases. It is also revealed that an increase in HIV infection in the population will positively influence the transmission of ZIKV. We validated the ZIKV only sub-model by fitting the ZIKV only sub-model to the confirmed cases of ZIKV data in Brazil. The outcome of the numerical simulations of HIV-ZIKV co-infection model reveals that the two diseases co-exist when their basic reproduction number surpasses one. Furthermore, increasing HIV treatment rate significantly reduces the burden of co-infection with the Zika virus.
... The virus can be transmitted from individuals with HIV through blood (certain bodily fluids) and sexual contact or vertically from an infected mother to her baby. However, only 51% of infected pregnant women receive treatment or prophylaxis to stop vertical transmission 3 . ...
Article
Full-text available
Objective: HIV patients differ from other people in terms of dental age. Estimating the age of children abandoned due to HIV is crucial for forensic records. The present study aimed to compare HIV-infected children with healthy controls in terms of dental age using the Willems method. Methods: The study sample consisted of orthopantomograms of 40 HIV patients aged 5-16 years and 50 children aged 6-16 years as the control group. The HIV group included children with vertical infections who had received antiretroviral therapy. The Willems method was used to compare two groups in terms of dental age. Results: Dental age estimation in both HIV and control groups was overestimated using the Willems method. Nevertheless, the overestimation rate was approximately one month in the control group and less than two months in the HIV group, making the method widely applicable for estimating dental age in both healthy children and HIV patients. The dental age of the HIV-infected children was lower than that of the control group. Conclusion: This study indicated a lower dental age in the HIV-infected children compared to the control group. The results demonstrated that dental age estimation using Willems method closely approximated the chronological age of HIV patients.
... It started to spread at a slow rate across Africa, which was then established globally. HIV is transmitted from one person to another through infected blood, vaginal fluids, semen, shared drug needles, mother to baby during pregnancy, breastfeeding, etc. (3)(4)(5). HIV is a retrovirus categorized under the class of RNA viruses that inserts its genetic material into human cells for replication (6). The size of the HIV is ~145 nm in diameter with a spherical shape (7). ...
Article
Full-text available
Acquired immunodeficiency syndrome (AIDS) is a deadly disease caused by human immunodeficiency virus (HIV) that has no complete cure up to date. Even though there are advancements in treatments, complete elimination of HIV from a patient’s body seems to be a challenge so far. The HIV-infected patients will be in the treatment phase throughout their lifecycle. However, with the recent advancement in nanotechnology, sherds of evidence to obtain a permanent solution for treating AIDS through targeted drug delivery are reported where nanoparticles are employed as drug vehicles/carriers. Nanotechnology routes can overcome the limitations faced by conventional treatment like reduced bioavailability, toxicity, deprived immune system, and blood-brain barrier. There are various nanoparticles which acts as vehicles/carriers which significantly help in the treatment and cure of HIV. However, understanding the spread of HIV infection and their conventional treatment is substantial for developing efficient nano drug delivery systems. This article aims providing the overview of HIV, highlighting their advancements, mechanisms, advantages, limitations, and the future perspectives of HIV with the use of nanotechnology. In this regard, this review emphasizes on the origin, replication, history of drug development, and nanotechnological advancement for HIV treatment.
... HIV transmission primarily occurs through three routes: sexual intercourse, exposure to contaminated blood through transfusions or shared needles, and from mother to child during pregnancy, childbirth, or breastfeeding. While homosexual transmission is a significant factor in the United States, heterosexual transmission remains the leading method of HIV spread worldwide (Kapila et al., 2016). The progression of HIV infection brings about varying symptoms. ...
Article
Full-text available
This paper investigates various epidemiological aspects of HIV/AIDS through a fractional-order mathematical model, emphasizing the role of treatment in the disease's transmission dynamics. Given the ongoing global impact of HIV/AIDS, with millions of people affected and significant mortality rates, understanding the complexities of its transmission and control is crucial for effective public health strategies. We establish conditions for the existence and uniqueness of the model’s solutions within the fractional framework and perform a stability analysis of the endemic equilibrium using the Lyapunov function method. Numerical simulations, executed via the fractional Adams–Bashforth–Moulton method, demonstrate the effects of model parameters and fractional-order values on HIV/AIDS dynamics and control. Additional simulations employing surface and contour plots reveal that higher contact rates and reduced treatment efficacy correlate with increased HIV/AIDS prevalence. Our findings suggest that optimizing treatment strategies can significantly lower the prevalence of HIV/AIDS within the population, ultimately contributing to enhanced health outcomes and resource allocation in combating this critical public health issue.
... When some participants claimed that HIV and AIDS were the same, it was inferred that they did not see any differences. According to Kapila et al. (2016), HIV is the human immunodeficiency virus that causes HIV infection, and AIDS is a condition in which the immune system progressively deteriorates, allowing life-threatening infections and malignancies to flourish. Closing such knowledge gaps is essential in order to reach the 95-95-95 targets. ...
Article
Full-text available
Background: The human immunodeficiency virus (HIV) epidemic in South Africa is among the worst in the world; in 2017, 38% of new infections were among young people aged 15–24 years. Estimates for HIV infection in 2020 worldwide indicate that there will be 1.5 million new cases, 10.2 million untreated cases (out of 37.7 million), and 680 000 deaths from acquired immunodeficiency syndrome (AIDS). Despite a 46% decline in new HIV infections among adolescents and youth over the previous 10 years, two of the seven new HIV infections in 2019 occurred in people between the ages of 15 and 24. HIV prevalence among young people has remained unchanged since 2008. This consistent pattern among people under 30 years of age indicates a failure in HIV prevention. Aim: The study aimed to explore HIV and sexual risk behaviours by 18–25-year-old youth at Nyandeni Municipality in the Eastern Cape province. Setting: The investigation was conducted Nyandeni Municipality in the Eastern Cape province. Methods: Qualitative approach was used to explore, describe and investigate the knowledge and attitudes about HIV among the 18–25 years old youth Results: The findings are based on three themes namely, knowledge and attitudes about HIV and AIDS in youth, sexual risk behaviour among youth, and HIV prevention strategies. Conclusion: This exploratory investigation confirms that the participants’ knowledge is limited by showing that most of them knew very little about HIV and AIDS infection and prevention. Ongoing educational initiatives are required. Contribution: Youth experience high HIV incidence because of their knowledge gaps.
... In the year 2022, 63 thousand people died from HIVrelated causes, while nearly 1 million people contracted HIV. 4 It spreads through contact with specific body fluids of an HIV-positive person, typically through unprotected sexual activity or sharing injecting supplies. 5 Additionally, HIV can be transmitted from mother to child through nursing or pregnancy. HIV is a retrovirus that affects the human immune system's dendritic cells, macrophages, and CD4þ T cells. ...
Article
HIV infection has been a severe global health burden, with millions living with the virus and continuing new infections each year. Antiretroviral therapy can effectively suppress HIV replication but requires strict lifelong adherence to daily oral medication regimens, which presents a significant challenge. Long‐acting formulations of antiretroviral drugs administered infrequently have emerged as a promising strategy to improve treatment outcomes and adherence to HIV therapy and prevention. Long‐acting injectable (LAI) formulations are designed to gradually release drugs over extended periods of weeks or months following a single injection. Critical advantages of LAIs over conventional oral dosage forms include less frequent dosing requirements, enhanced patient privacy, reduced stigma associated with daily pill regimens, and optimised pharmacokinetic/pharmacodynamic profiles. Several LAI antiretroviral products have recently gained regulatory approval, such as the integrase strand transfer inhibitor cabotegravir for HIV preexposure prophylaxis and the Cabotegravir/Rilpivirine combination for HIV treatment. A leading approach for developing long‐acting antiretroviral depots involves encapsulating drug compounds in polymeric microspheres composed of biocompatible, biodegradable materials like poly (lactic‐co‐glycolic acid). These injectable depot formulations enable high drug loading with customisable extended‐release kinetics controlled by the polymeric matrix. Compared to daily oral therapies, LAI antiretroviral formulations leveraging biodegradable polymeric microspheres offer notable benefits, including prolonged therapeutic effects, reduced dosing frequency for improved adherence, and the potential to kerb the initial HIV transmission event. The present manuscript aims to review the pathogenesis of the virus and its progression and propose therapeutic targets and long‐acting drug delivery strategies that hold substantial promise for enhancing outcomes in HIV treatment and prevention.
... HIV infection and AIDS are caused by HIV. 1 There are two types of HIV virus, namely HIV type 1 (HIV-1) and HIV type 2 (HIV-2). HIV disease in the world is generally caused by HIV-1, while HIV-2 is found to be endemic in West Africa. 2 4 Based on global data, HIV/AIDS remains a major health problem worldwide. ...
Article
Full-text available
Background Currently, human immunodeficiency virus and acquired immunodeficiency syndrome (HIV/AIDS) has become one of the major health problems worldwide, including Indonesia. East Java is one of the provinces in Indonesia with the highest prevalence of HIV infection. One of the causes of HIV infection transmission is lesbian, gay, bisexual, and transgender (LGBT) practice. Furthermore, the treatment using antiretroviral (ARV) drugs in HIV-1 patients can fail due to the presence of HIV drug resistance. Objective The aim of this study is to identify the behavior at risk of HIV transmission among LGBT, patterns of genetic variation and antiretroviral (ARV) resistance. Methods A systematic review and meta-analysis based on the PRISMA guidelines was conducted. We searched three databases including PubMed, ScienceDirect, and Google scholar for studies investigating the non-heterosexual behavior as risk factor of HIV infection and antiretroviral resistance. Only studies published in English are considered. The adjusted estimates of the risk were carried out using best-adjusted OR with 95% confidence interval (CI) and significant p value < 0.05. Results In the quantitative analysis of HIV infection risk factors, a total of 13 studies were included, which investigated non-heterosexual behavior as a potential factor. The studies involved a total of 37,129 participants, comprising 10,449 individuals in the non-heterosexual behavior group (LGBTQ+) and 26,680 individuals in the heterosexual group. The majority of the participants in this study were from the USA, Japan, China, and Brazil, and the main HIV subgenotypes were B and CRF. Additionally, the antiretroviral resistance of HIV patients was examined, involving a total of 3062 individuals, with 1296 individuals in the non-heterosexual behavior group and 1766 individuals in the heterosexual group. Our calculation showed that non-heterosexual behavior was significant as risk factor of HIV infection (OR = 2.17, 95% CI = 1.94–2.43, p < 0.001) and antiretroviral resistance (OR = 1.31, 95% CI = 1.00–1.71, p = 0.05). Conclusion This study concludes that non heterosexual behavior is significant risk factor of HIV infection. A quite prevalent of antiretroviral resistance were found among non heterosexual behavior. The main subgenotype of HIV are B and CRF.
Article
Sexually Transmitted Disease (STDs) is a group of infection which is responsible for morbidity and mortality in developing country. This group of infections plays its role in the transmission of the Human Immunodeficiency Virus (HIV). DKI Jakarta, Papua, and East Java are the provinces responsible for 90% of the STD incidence. STDs are caused by 30 types of bacteria, viruses, parasites, and fungi, which are transmitted by sexual contact and are asymptomatic. This study used a cross-sectional approach and a univariate test. The result is Hepatitis B was most found in 2017, as many as 30,7%; Hepatitis C in 2017, as many as 24,7%; Syphilis in 2017, as many as 25,9%; and HIV in 2018, as many as 27,2%. Keywords: STD, blood screening, HIV
Chapter
One of the most disruptive and game-changer events in the history of medicine, thus humankind, was the discovery of penicillin by Alexander Fleming in the twentieth century. Fleming’s work paved the way for modern antimicrobial therapies that have dramatically impacted the human lifespan. Nevertheless, as with almost any other medication, unexpected adverse drug reactions and other related factors affect the efficacy and overall patients’ outcome. Since the “genomic revolution” started, it is well known that both the host and the pathogen’s genetic information plays a crucial role in treatment response, thus, outcome. In this chapter, using a clinical utility lens, the implications of pharmacogenomics in infectious diseases in an evidence-based approach will be discussed.
Article
The objective of this study was to investigate the relationship between the number of unprotected heterosexual contacts with an HIV-infected person and the probability of HIV transmission. Data from a European study involving 563 heterosexual partners of HIV-infected subjects were analyzed. The number of unprotected contacts could be estimated for 525 couples (377 with male index case, 148 with female index case) from the reported frequency of unprotected contacts and an estimate of the length of the period during which transmission could have occurred. Nonparametric (isotonic regression) and parametric (Bernoulli model) analyses were performed on data at study entry and on follow-up data (121 couples). The nonparametric analysis resulted in several exposure groups, with the proportion of infected partners increasing with the number of contacts. For example, the percentage of female partners infected ranged from 10%, among those with < 10 unprotected contacts with an infected male, to 23% after 2,000 unprotected contacts. The parametric estimates of (assumed constant) per-contact infectivity were higher for male-to-female than for female-to-male transmission, but not significantly so. However, in comparison with nonparametric estimates, the model assuming constant infectivity appears to seriously underestimate the risk after very few contacts and to seriously overestimate the risk associated with a large number of contacts. Our results suggest that the association between the number of unprotected sexual contacts and the probability of infection is weak and highly inconsistent with constant per-contact infectivity. Probable explanations for these findings include large variability in infectivity between couples and within individuals over time. Estimates based on partner study data under the hypothesis of constant infectivity can, therefore, be highly misleading at a public health level, particularly when extrapolated to multiple casual contacts.
Article
By the acute stage of HIV-1 infection, the immune system already faces daunting challenges. Research on mucosal barriers and the events immediately after heterosexual transmission that precede this acute stage could facilitate the development of effective microbicides and vaccines.
Epidemiology, natural history and Pathogenesis of HIV Infection
  • J Amborzia
  • J A Levy
Amborzia, J. and Levy J. A. Epidemiology, natural history and Pathogenesis of HIV Infection. In Sexually Transmitted Diseases, 3d ed, ed. K.K. Holmes, P.F. Sparling, P.A. Mardh, S.M. Lemon, W.E. Stamm, P. Piot, and J.N. Wasserheit, 1998; 251-58.
Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus Infection
  • F J Palella
  • K M Delaney
  • A C Moorman
  • M O Loveless
  • J Fuhrer
  • G A Satten
  • D J Aschman
  • S D Holmberg
Palella, F.J., Delaney, K.M., Moorman, A.C., Loveless, M.O., Fuhrer, J., Satten, G.A., Aschman, D.J. and Holmberg, S.D. Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus Infection; N England Journal of Medicine 1998; 338: 853-860.
Jaypee brothers, medical publishers ltd
  • K D Tripathi
Tripathi, K.D. Essentials of Medical Pharmacology, 6 th edition, Jaypee brothers, medical publishers ltd., New Delhi; 798-810.